000			01802 a2200481 4500
005			20250517113648.0
264		0	_c20171030
008			201710s 0 0 eng d
022			_a1953-8022
024	7		_a10.1016/j.tracli.2016.08.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aLe Gouez, A
245	0	0	_aMajor obstetric hemorrhage. _h[electronic resource]
260			_bTransfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine _cNov 2016
300			_a229-232 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aBlood Component Transfusion
650	0	4	_aCombined Modality Therapy
650	0	4	_aDinoprostone _xanalogs & derivatives
650	0	4	_aFactor VIIa _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFibrinogen _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aHysterectomy
650	0	4	_aIliac Artery _xsurgery
650	0	4	_aLigation
650	0	4	_aMaternal Mortality
650	0	4	_aOperative Blood Salvage
650	0	4	_aPlacenta Accreta _xphysiopathology
650	0	4	_aPlacenta Previa _xphysiopathology
650	0	4	_aPostpartum Hemorrhage _xetiology
650	0	4	_aPregnancy
650	0	4	_aPregnancy Complications _xprevention & control
650	0	4	_aRecombinant Proteins _xtherapeutic use
650	0	4	_aTranexamic Acid _xtherapeutic use
650	0	4	_aUterine Artery _xsurgery
650	0	4	_aUterine Artery Embolization
650	0	4	_aUterine Hemorrhage _xprevention & control
650	0	4	_aUterine Inertia _xdrug therapy
700	1		_aMercier, F J
773	0		_tTransfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine _gvol. 23 _gno. 4 _gp. 229-232
856	4	0	_uhttps://doi.org/10.1016/j.tracli.2016.08.003 _zAvailable from publisher's website
999			_c26387621 _d26387621